Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,370 | 1 | 85.1% |
| Food and Beverage | $764.79 | 9 | 14.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $4,490 | 2 | $0 (2024) |
| Relypsa, Inc. | $264.75 | 3 | $0 (2019) |
| Covidien LP | $233.02 | 2 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $128.81 | 2 | $0 (2023) |
| Boston Scientific Corporation | $18.21 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.00 | 1 | GlaxoSmithKline, LLC. ($120.00) |
| 2023 | $119.14 | 2 | Aurinia Pharma U.S., Inc. ($100.93) |
| 2022 | $4,398 | 2 | GlaxoSmithKline, LLC. ($4,370) |
| 2019 | $181.31 | 2 | Covidien LP ($97.67) |
| 2018 | $181.11 | 2 | Relypsa, Inc. ($181.11) |
| 2017 | $135.35 | 1 | Covidien LP ($135.35) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $120.00 | General |
| 05/17/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 03/07/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $100.93 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/07/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/09/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,370.00 | General |
| 06/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $83.64 | General |
| Category: Hyperkalemia | ||||||
| 02/08/2019 | Covidien LP | Situate (Device) | Food and Beverage | In-kind items and services | $97.67 | General |
| Category: OR Safety | ||||||
| 11/20/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $71.55 | General |
| Category: Hyperkalemia | ||||||
| 09/05/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $109.56 | General |
| Category: Hyperkalemia | ||||||
| 11/10/2017 | Covidien LP | — | Food and Beverage | In-kind items and services | $135.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 187 | 329 | $77,790 | $34,503 |
| 2022 | 5 | 174 | 297 | $59,925 | $25,019 |
| 2021 | 6 | 150 | 221 | $47,725 | $21,101 |
| 2020 | 8 | 212 | 306 | $71,580 | $28,522 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 76 | $19,760 | $10,416 | 52.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 17 | 23 | $14,260 | $5,939 | 41.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 55 | $11,000 | $5,467 | 49.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 79 | $11,060 | $5,220 | 47.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 21 | 41 | $9,430 | $2,440 | 25.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,880 | $2,177 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 20 | $4,000 | $1,830 | 45.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 15 | $2,400 | $1,014 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 63 | $16,380 | $9,228 | 56.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 97 | $13,610 | $5,841 | 42.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 46 | 77 | $17,710 | $4,756 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 45 | $9,000 | $3,908 | 43.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 15 | $3,225 | $1,287 | 39.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 48 | $12,480 | $7,220 | 57.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 43 | $8,600 | $3,782 | 44.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 51 | $7,185 | $3,061 | 42.6% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 18 | 42 | $9,660 | $2,511 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 25 | $5,000 | $2,479 | 49.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $4,800 | $2,047 | 42.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 53 | 81 | $21,495 | $8,906 | 41.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 53 | $10,600 | $4,796 | 45.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $12,590 | $4,506 | 35.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 42 | $5,880 | $2,638 | 44.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 25 | 40 | $9,200 | $2,555 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 28 | $5,600 | $2,444 | 43.6% |
About Dr. Iris Lee, M.D
Dr. Iris Lee, M.D is a Nephrology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861593782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iris Lee, M.D has received a total of $5,135 in payments from pharmaceutical and medical device companies, with $120.00 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($4,370).
As a Medicare-enrolled provider, Lee has provided services to 723 Medicare beneficiaries, totaling 1,153 services with total Medicare billing of $109,145. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Philadelphia, PA
- Active Since 09/25/2006
- Last Updated 08/27/2019
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1861593782
Products in Payments
- Veltassa (Drug) $264.75
- LUPKYNIS (Drug) $128.81
- Situate (Device) $97.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Philadelphia
Dr. Rakesh Gulati, Md, MD
Nephrology — Payments: $602,663
Raymond Townsend, Md, MD
Nephrology — Payments: $348,680
Ellie Kelepouris, Md, MD
Nephrology — Payments: $289,837
Katalin Susztak, Md, MD
Nephrology — Payments: $164,350
Jonathan Hogan, Md, MD
Nephrology — Payments: $106,471
Debbie Cohen Stein, Md, MD
Nephrology — Payments: $92,545